Evidence map›Paper›PMID 35609016›Full record

ArticlePloS one2022

Anxiety, depression, and substance experimentation in childhood.

Robert J Klein, Joseph A Gyorda, Nicholas C Jacobson

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07074860 (Clinical Screening and Peer Interventions to Prevent Substance Use in At-Risk Adolescents), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07074860 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Clinical Screening and Peer Interventions to Prevent Substance Use in At-Risk Adolescents

TypeinterventionalSponsorUniversity of VermontRan2025 to 2027Enrolled50ConditionsInitation of Substance Use DisorderArmsPeer to peer video to raise awareness about substance use
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert J KleinGeisel School of Medicine at Dartmouth College, Hanover, NH, United States of America.ORCID 0000-0001-6143-787X
Joseph A GyordaGeisel School of Medicine at Dartmouth College, Hanover, NH, United States of America.
Nicholas C JacobsonGeisel School of Medicine at Dartmouth College, Hanover, NH, United States of America.

Funding

Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
NIDA NIH HHS P30 DA029926NIDA NIH HHS T32 DA037202
6 · The paper itself

Abstract

Previous research has demonstrated that adults with comorbid depressive and anxiety disorders are significantly more likely to show pathological use of drugs or alcohol. Few studies, however, have examined associations of this type in children. A better understanding of the relationships between affective disorders and substance experimentation in childhood could help clarify the complex ways in which pathological substance use symptoms develop early in life. The present study included 11,785 children (Mage = 9.9) participating in the Adolescent Brain Cognitive Development (ABCD) study. Depressive and anxiety disorder diagnoses were evaluated as concurrent predictors of experimentation with alcohol and tobacco. A series of linear regressions revealed that children with either depressive or anxiety disorders were significantly more likely to experiment with alcohol or tobacco. However, children with both depressive and anxiety diagnoses were not more likely to experiment than children without a diagnosis. These results suggest that anxiety or depressive diagnoses in childhood may be associated with a greater likelihood of substance experimentation, but severe psychological distress may suppress these effects.

Indexed as

DepressionSubstance-Related DisordersAdolescentAdultAnxietyAnxiety DisordersChildComorbidityHumans

Identifiers

PMID35609016
PMCPMC9129013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.